Neurology
Found 631 results
2022
Parasram M, Arevalo-Perez J.  2022.  Cerebral toxoplasmosis in a patient with multiple myeloma.. Surg Neurol Int. 13:191.
De Michele M, Kahan J, Berto I, Schiavo OG, Iacobucci M, Toni D, Merkler AE.  2022.  Cerebrovascular Complications of COVID-19 and COVID-19 Vaccination.. Circ Res. 130(8):1187-1203.
Tripathi S, Malhotra A, Qazi M, Chou J, Wang F, Barkan S, Hellmers N, Henchcliffe C, Sarva H.  2022.  Clinical Review of Smartphone Applications in Parkinson Disease.. Neurologist.
Kahan J, Ong H, Ch'ang J, Merkler AE, Fink ME, Gupta A, Kamel H, Murthy SB.  2022.  Comparing hematoma characteristics in primary intracerebral hemorrhage versus intracerebral hemorrhage caused by structural vascular lesions.. J Clin Neurosci. 99:5-9.
Hoang HEthan, Robinson-Papp J, Mu L, Thakur KT, Gofshteyn JSarah, Kim C, Ssonko V, Dugue R, Harrigan E, Glassberg B et al..  2022.  Determining an infectious or autoimmune etiology in encephalitis.. Ann Clin Transl Neurol.
Zinger N, Ponath G, Sweeney E, Nguyen TD, Lo CHung, Diaz I, Dimov A, Teng L, Zexter L, Comunale J et al..  2022.  Dimethyl Fumarate Reduces Inflammation in Chronic Active Multiple Sclerosis Lesions.. Neurol Neuroimmunol Neuroinflamm. 9(2)
Marcille M, Rúa SHurtado, Tyshkov C, Jaywant A, Comunale J, Kaunzner UW, Nealon N, Perumal JS, Zexter L, Zinger N et al..  2022.  Disease correlates of rim lesions on quantitative susceptibility mapping in multiple sclerosis.. Sci Rep. 12(1):4411.
Koch C, Bagnato F, Laule C, Gauthier SA.  2022.  Editorial: Measuring progression in Multiple Sclerosis: Progressing beyond the ordinary.. Front Hum Neurosci. 16:1095208.
Qing KY, Forgacs PB, Schiff ND.  2022.  EEG Pattern With Spectral Analysis Can Prognosticate Good and Poor Neurologic Outcomes After Cardiac Arrest.. J Clin Neurophysiol.
Robbins MStuart.  2022.  Finding Fellowship In Neurology Fellowship Recruitment.. Neurology.
Michaelson NMiriam, Schiff ND, Bernat JL.  2022.  Fred Plum (1924-2010).. J Neurol.
Gao V, Briano JA, Komer L, Burré J.  2022.  Functional and pathological effects of α-synuclein on synaptic SNARE complexes.. J Mol Biol. :167714.
Dimov AV, Nguyen TD, Spincemaille P, Sweeney EM, Zinger N, Kovanlikaya I, Kopell BH, Gauthier SA, Wang Y.  2022.  Global cerebrospinal fluid as a zero-reference regularization for brain quantitative susceptibility mapping.. J Neuroimaging. 32(1):141-147.
Kanegi SL, Zhang N, Armand CE, Singh RBHalker, Robbins MS, Vinokur M, Lee J, Rosen N.  2022.  Headache fellowship match shareholder insights.. Headache.
Perumal J, Balabanov R, Su R, Chang R, Balcer LJ, Galetta SL, Avila RL, Rutledge D, Fox RJ.  2022.  Improvements in Cognitive Processing Speed, Disability, and Patient-Reported Outcomes in Patients with Early Relapsing-Remitting Multiple Sclerosis Treated with Natalizumab: Results of a 4-year, Real-World, Open-Label Study.. CNS Drugs. 36(9):977-993.
Azary S, Caravanos C, Reiner AS, Panageas KS, Dhawan V, Avila EK.  2022.  Incidence of Seizure and Associated Risk Factors in Patients in the Medical Intensive Care Unit (ICU) at Memorial Sloan Kettering Cancer Center (MSK) from 2016-2017.. J Intensive Care Med. :8850666211066080.
Rúa SMHurtado, Kaunzner UW, Pandya S, Sweeney E, Tozlu C, Kuceyeski A, Nguyen TD, Gauthier SA.  2022.  Lesion features on magnetic resonance imaging discriminate multiple sclerosis patients.. Eur J Neurol. 29(1):237-246.
Dimov AV, Gillen KM, Nguyen TD, Kang J, Sharma R, Pitt D, Gauthier SA, Wang Y.  2022.  Magnetic Susceptibility Source Separation Solely from Gradient Echo Data: Histological Validation.. Tomography. 8(3):1544-1551.
Dominguez M, Di Stefano G.  2022.  Novel ways of approaching the pharmacologic treatment of trigeminal neuralgia.. Headache.
Parasram M, Roytman M, Lee A, Ivanidze J.  2022.  Posterior cortical atrophy.. J Osteopath Med.
Michaelson NM, Ch'ang JH.  2022.  The Power of Our Words.. Acad Med.
Zhang H, Nguyen TD, Zhang J, Marcille M, Spincemaille P, Wang Y, Gauthier SA, Sweeney EM.  2022.  QSMRim-Net: Imbalance-aware learning for identification of chronic active multiple sclerosis lesions on quantitative susceptibility maps.. Neuroimage Clin. 34:102979.
Huang W, Sweeney EM, Kaunzner UW, Wang Y, Gauthier SA, Nguyen TD.  2022.  Quantitative susceptibility mapping versus phase imaging to identify multiple sclerosis iron rim lesions with demyelination.. J Neuroimaging. 32(4):667-675.
Michaelson NMiriam, Malhotra A, J Chazen L, Weaver J.  2022.  Rare presentation of spontaneously occurring intravertebral lumbar pseudomeningocele.. Acta Neurol Belg.
Oh SE, Parikh NS.  2022.  Recent Advances in the Impact of Infection and Inflammation on Stroke Risk and Outcomes.. Curr Neurol Neurosci Rep.